Skip to content
evidenceevidencedocumentFederal Criminal TrialA 2013 document to the FDA describing Theranos's two-phase Walgreens approach and use of conventional commercial analyzersDescribes Theranos's two-phase Walgreens approach and its use of conventional commercial analyzers in a 2013 document to the FDA.
← All Evidence
Documents & Records

A 2013 document to the FDA describing Theranos's two-phase Walgreens approach and use of conventional commercial analyzers

Describes Theranos's two-phase Walgreens approach and its use of conventional commercial analyzers in a 2013 document to the FDA.

1 proceeding1 mention1 trial

Trial Record (1)